adenosine has been researched along with Lupus Erythematosus, Systemic in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (44.83) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (10.34) | 29.6817 |
| 2010's | 7 (24.14) | 24.3611 |
| 2020's | 6 (20.69) | 2.80 |
| Authors | Studies |
|---|---|
| Alter, C; Braband, R; Hesse, J; Honke, N; Pongratz, G; Schallehn, M; Schneider, M; Schnieringer, ML; Schrader, J; Siekierka-Harreis, M; Steckel, B; Surowy, H; Wieczorek, D; Wippich, M | 1 |
| Deng, LJ; Fan, YG; Leng, RX; Pan, HF; Wu, J; Xia, YR; Ye, DQ | 1 |
| Dong, R; Ge, L; Guo, J; Ni, B; Shi, Y; Song, Z; Wang, J; You, Y; Zhang, L; Zhao, X | 1 |
| Ge, L; He, X; Ni, B; Ruan, Z; Song, Z; Wang, J; You, Y; Zhao, X | 1 |
| Fu, B; Guo, Y; Huang, Z; Li, J; Luo, Q; Zhang, L | 1 |
| Chaimovitz, C; Douvdevani, A; Haviv, YS; Mazar, J; Naamani, O; Riff, R | 1 |
| Fan, YG; Leng, RX; Li, LJ; Pan, HF; Ye, DQ | 1 |
| Bahn, JH; Brümmer, A; Graveley, BR; Jun, HI; Pratt, GA; Quinones-Valdez, G; Tran, SS; Van Nostrand, EL; Wei, X; Xiao, X; Yang, EW; Yeo, GW; Zhan, L | 1 |
| Farkash, EA; He, Y; Rohraff, DM; Sawalha, AH; Schonfeld, M; Tsou, PS | 1 |
| Barber, DF; Cariaga, AE; Carrera, AC; García, E; Puri, KD; Rojas, JM; Steiner, BH; Suárez-Fueyo, A | 1 |
| Camici, PG; Harari, OA; Kaski, JC; Mason, JC; Recio-Mayoral, A; Rubens, MB | 1 |
| Chen, M; Huang, B; Li, F; Li, Y; Liang, Y; Tan, H; Wang, S; Yang, N; Yu, X; Zhang, L | 1 |
| Sipka, S | 1 |
| Anderson, AS; Khan, IU; Loza, MJ; O'Rourke, KS; Wood, J | 1 |
| Bagi, Z; Hamar, P; Kardos, M; Koller, A | 1 |
| Chowdhury, B; Fisher, CU; Krishnan, S; Nambiar, MP; Robertson, JW; Tsokos, CG; Tsokos, GC | 1 |
| Webster, HK | 1 |
| Borel, Y; Morimoto, C; Schlossman, SF; Steinberg, AD | 1 |
| Birch, RE; Kammer, GM; Polmar, SH | 1 |
| Birch, RE; Kammer, GM; Mandler, R; Polmar, SH; Rudolph, SA | 1 |
| Barnett, EV; Garrett, RA; Katz, DH; Liebling, MR; Paulus, HE; Weisbart, RH | 1 |
| Alarcón-Segovia, D; Estrada-Parra, S; Fishbein, E; García-Ortigoza, E | 2 |
| Imai, Y; Naiki, M; Osawa, T | 1 |
| Kammer, GM; Mitchell, E | 1 |
| Kammer, GM; Rudolph, SA; Schultz, LA | 1 |
| Bonavida, B; Fuchs, S; Sela, M | 1 |
| Borel, Y; Lewis, RM; Stollar, BD | 1 |
| Agnello, V; Koffler, D; Kunkel, HG; Winchester, R | 1 |
3 review(s) available for adenosine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Potential link between m
Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Epigenesis, Genetic; Gene Expression Regulation; HIV Infections; Humans; Lupus Erythematosus, Systemic; Methyltransferases; Neoplasms; Nucleic Acid Conformation; Protein Biosynthesis; RNA Precursors; RNA Processing, Post-Transcriptional; RNA Splicing; RNA Stability; RNA-Binding Proteins | 2018 |
Adenosine inhibits the release of arachidonic acid in activated human peripheral mononuclear cells. A proposed model for physiologic and pathologic regulation in systemic lupus erythematosus.
Topics: Adenosine; Arachidonic Acid; Humans; Interleukin-1beta; Lupus Erythematosus, Systemic; Models, Biological; Monocytes, Activated Killer; Protein Kinase C | 2011 |
Role of purines in lymphocyte function.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Deaminase; Animals; Cyclic AMP; Humans; Immunologic Deficiency Syndromes; Lupus Erythematosus, Systemic; Lymphocyte Activation; Lymphocytes; Macaca fascicularis; Malaria; Nucleotidases; Purine-Nucleoside Phosphorylase; Purine-Pyrimidine Metabolism, Inborn Errors; Purines; Receptors, Cell Surface; Receptors, Purinergic; T-Lymphocytes | 1984 |
26 other study(ies) available for adenosine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Profound inhibition of CD73-dependent formation of anti-inflammatory adenosine in B cells of SLE patients.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; B-Lymphocytes; Biomarkers; Biosynthetic Pathways; Case-Control Studies; Chromatography, High Pressure Liquid; Disease Susceptibility; Female; GPI-Linked Proteins; Humans; Immunophenotyping; Leukocytes; Lupus Erythematosus, Systemic; Male; Severity of Illness Index | 2021 |
Involvement of N6-methyladenosine modifications of long noncoding RNAs in systemic lupus erythematosus.
Topics: Adenosine; Adult; Base Sequence; Case-Control Studies; Female; Gene Expression Profiling; Gene Expression Regulation; Humans; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Male; Methylation; Middle Aged; Reproducibility of Results; RNA, Long Noncoding; RNA, Messenger; T-Lymphocytes | 2022 |
N6-methyladenosine-dependent modification of circGARS acts as a new player that promotes SLE progression through the NF-κB/A20 axis.
Topics: Adenosine; Humans; In Situ Hybridization, Fluorescence; Lupus Erythematosus, Systemic; NF-kappa B; RNA, Circular; Tumor Necrosis Factor alpha-Induced Protein 3 | 2022 |
Exploration of Potential Integrated Models of N6-Methyladenosine Immunity in Systemic Lupus Erythematosus by Bioinformatic Analyses.
Topics: Adenosine; Computational Biology; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Lupus Erythematosus, Systemic | 2021 |
Decreased Peripheral Blood
Topics: Adenosine; Adult; AlkB Homolog 5, RNA Demethylase; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Autoantibodies; Biomarkers; Cell Cycle Proteins; Female; Gene Expression; Humans; Lupus Erythematosus, Systemic; Male; Methyltransferases; Middle Aged; Reproducibility of Results; RNA Splicing Factors; RNA-Binding Proteins; RNA, Messenger | 2020 |
A
Topics: Adenosine; Animals; Autoimmunity; Diabetes Mellitus, Type 1; Disease Models, Animal; Extracellular Traps; Lupus Erythematosus, Systemic; Lymphopenia; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Neutrophil Activation; Neutrophils; Receptor, Adenosine A1; Receptor, Adenosine A2A; RNA, Messenger; Signal Transduction; Streptozocin; Terpenes | 2021 |
Regulation of RNA editing by RNA-binding proteins in human cells.
Topics: Adenosine; Adenosine Deaminase; Alu Elements; Autoantigens; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Hep G2 Cells; Humans; Inosine; K562 Cells; Lupus Erythematosus, Systemic; Ribonucleoproteins; RNA Editing; RNA-Binding Proteins; RNA, Small Cytoplasmic; Sequence Analysis, RNA; Transcription, Genetic; Transfection | 2019 |
Inhibition of EZH2 Ameliorates Lupus-Like Disease in MRL/lpr Mice.
Topics: Adenosine; Adult; Animals; Antibodies, Antinuclear; Antibody Formation; B-Lymphocytes; CD4-Positive T-Lymphocytes; Cell Proliferation; Cytokines; Enhancer of Zeste Homolog 2 Protein; Female; Humans; Kidney; Lupus Erythematosus, Systemic; Lymph Nodes; Lymphocyte Count; Male; Mice; Mice, Inbred MRL lpr; Middle Aged; Monocytes; Neutrophils; Proteinuria; RNA, Messenger; Spleen; Survival Rate; T-Lymphocytes | 2019 |
Inhibition of PI3Kδ reduces kidney infiltration by macrophages and ameliorates systemic lupus in the mouse.
Topics: Adenosine; Animals; Antibodies, Antinuclear; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Class I Phosphatidylinositol 3-Kinases; Class Ib Phosphatidylinositol 3-Kinase; Cytokines; Dose-Response Relationship, Drug; Flow Cytometry; Immunoglobulin G; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphocyte Count; Macrophages; Mice; Mice, Inbred C57BL; Mice, Inbred MRL lpr; Microscopy, Confocal; Molecular Structure; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Quinazolinones; Quinoxalines; Survival Analysis; Thiazolidinediones | 2014 |
Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease.
Topics: Adenosine; Adult; Arthritis, Rheumatoid; Case-Control Studies; Coronary Artery Disease; Coronary Circulation; Endothelium, Vascular; Female; Fractional Flow Reserve, Myocardial; Humans; Inflammation; Lupus Erythematosus, Systemic; Male; Microcirculation; Positron-Emission Tomography; Prospective Studies; Risk Assessment; Vasodilator Agents | 2009 |
Adenosine 2A receptor is protective against renal injury in MRL/lpr mice.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Blotting, Western; Disease Models, Animal; Disease Progression; Female; Gene Expression; Inflammation; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred MRL lpr; Phenethylamines; Receptor, Adenosine A2A; Reverse Transcriptase Polymerase Chain Reaction; RNA | 2011 |
T-cell specific defect in expression of the NTPDase CD39 as a biomarker for lupus.
Topics: Adenosine; Adult; Aged; Antigens, CD; Apyrase; Biomarkers; Cell Proliferation; Cells, Cultured; Flow Cytometry; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Middle Aged; T-Lymphocytes; T-Lymphocytes, Regulatory; Xanthines | 2011 |
Lack of flow-mediated dilation and enhanced angiotensin II-induced constriction in skeletal muscle arterioles of lupus-prone autoimmune mice.
Topics: Acetylcholine; Adenosine; Angiotensin II; Animals; Antibodies, Antinuclear; Arterioles; Blood Pressure; Bradykinin; Disease Models, Animal; Endothelium, Vascular; Female; Hemorheology; Lupus Erythematosus, Systemic; Mice; Mice, Inbred MRL lpr; Muscle, Skeletal; Nitroprusside; Serotonin; Vasoconstriction; Vasodilation; Vasodilator Agents | 2006 |
Stability and translation of TCR zeta mRNA are regulated by the adenosine-uridine-rich elements in splice-deleted 3' untranslated region of zeta-chain.
Topics: 3' Untranslated Regions; Adenosine; Alternative Splicing; Base Sequence; Humans; Lupus Erythematosus, Systemic; Membrane Proteins; Molecular Sequence Data; Protein Biosynthesis; Receptors, Antigen, T-Cell; RNA Stability; RNA, Messenger; Transcription, Genetic; Uridine | 2006 |
In vitro nucleoside specific immune response by lymphocytes from systemic lupus erythematosus.
Topics: Adenosine; Antibody Specificity; Antigens; Cell Division; Cells, Cultured; Cytidine; gamma-Globulins; Guanosine; Hemocyanins; Humans; Lupus Erythematosus, Systemic; Lymphocytes; Nucleosides; Pokeweed Mitogens; Thymidine | 1983 |
Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
Topics: Adenosine; Female; Humans; Immunosuppressive Agents; Isoantigens; Lupus Erythematosus, Systemic; Lymphocyte Activation; Male; Mitogens; Phenotype; Receptors, Antigen, T-Cell; Receptors, Fc; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory | 1983 |
Abnormal adenosine-induced immunosuppression and cAMP metabolism in T lymphocytes of patients with systemic lupus erythematosus.
Topics: Adenosine; Antigens, Surface; Cyclic AMP; Drug Resistance; Humans; Immune Tolerance; Lupus Erythematosus, Systemic; Molecular Weight; Receptors, Cell Surface; Receptors, Cyclic AMP; Receptors, Fc; Receptors, Purinergic; T-Lymphocytes; T-Lymphocytes, Helper-Inducer; Theophylline | 1982 |
Specificity of anti-nucleoside antibodies in systemic lupus erythematosus.
Topics: Adenosine; Antibodies, Antinuclear; Antibody Specificity; Binding Sites, Antibody; Cytidine; DNA, Single-Stranded; Guanosine; Humans; Immunoglobulin G; Lupus Erythematosus, Systemic; Nucleosides | 1983 |
Uracil-specific anti-R.N.A. antibodies in scleroderma.
Topics: Adenosine; Adenosine Monophosphate; Animals; Antibodies; Cattle; Cross Reactions; Cytidine; Cytosine Nucleotides; Epitopes; Guanine Nucleotides; Guanosine; Humans; Immunoelectrophoresis; Lupus Erythematosus, Systemic; Precipitins; RNA; Scleroderma, Systemic; Serum Albumin; Thymidine; Thymine Nucleotides; Uracil; Uracil Nucleotides; Uridine | 1975 |
Immunochemical characterization of the anti-RNA antibodies found in scleroderma and systemic lupus erythematosus. II. Reactivity with hsa-coupled, uridine-containing, monophosphoric ribodinucleotides.
Topics: Adenosine; Antibodies, Antinuclear; Counterimmunoelectrophoresis; DNA; Humans; Lupus Erythematosus, Systemic; Oligonucleotides; Poly A-U; Poly U; RNA; Scleroderma, Systemic; Serum Albumin; Uracil Nucleotides; Uridine; Uridine Monophosphate | 1976 |
Establishment of a nucleoside-specific suppressor T cell line from SLE prone (NZB/NZW)F1 mice.
Topics: Adenosine; Animals; Antibody Formation; Cell Line; Cross Reactions; Crosses, Genetic; Cytidine; Epitopes; Female; Guanosine; Immune Tolerance; Lupus Erythematosus, Systemic; Lymphocyte Activation; Mice; Mice, Inbred NZB; T-Lymphocytes, Regulatory; Thymidine; Time Factors | 1985 |
Impaired mobility of human T lymphocyte surface molecules during inactive systemic lupus erythematosus. Relationship to a defective cAMP pathway.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenosine; Adult; Antigens, Surface; Azides; Colforsin; Cyclic AMP; Female; Humans; Immunologic Capping; Lupus Erythematosus, Systemic; Male; Receptors, Cyclic AMP; T-Lymphocytes | 1988 |
Characterization of the human T lymphocyte adenosine receptor: comparison of normal and systemic lupus erythematosus cells.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Binding Sites; Binding, Competitive; Cell Membrane; Female; Humans; Lupus Erythematosus, Systemic; Receptors, Purinergic; Reference Values; T-Lymphocytes | 1988 |
Nucleoside-coated bacteriophage T4: a method for the detection and characterization of anti-nucleoside antibodies.
Topics: Adenosine; Animals; Antibodies; Antigen-Antibody Reactions; Coliphages; Complement System Proteins; Cross Reactions; Cytidine; DNA; Goats; Guanosine; Humans; Immune Sera; Inosine; Lupus Erythematosus, Systemic; Nucleosides; Periodic Acid; Rabbits; RNA, Transfer; Uridine | 1972 |
Prevention of murine lupus nephritis by carrier-dependent induction of immunologic tolerance to denatured DNA.
Topics: Adenosine; Age Factors; Animals; Antibodies, Antinuclear; Antibody Formation; Carrier Proteins; Cytosine; DNA; Erythrocytes; Guanosine; Immune Tolerance; Immunization; Immunoglobulin G; Kidney Diseases; Lupus Erythematosus, Systemic; Mice; Mice, Inbred NZB; Nucleic Acid Denaturation; Nucleosides; Protein Binding; Serum Albumin, Bovine; Sheep; Thymidine | 1973 |
The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases.
Topics: Adenosine; Animals; Antigen-Antibody Complex; Antigens; Arthritis, Rheumatoid; Cattle; DNA; DNA, Single-Stranded; Glomerulonephritis; Hemagglutination Inhibition Tests; Humans; Immunodiffusion; Leukemia; Lupus Erythematosus, Systemic; Methods; Neoplasms; Rabbits; Serum Albumin; Thymidine | 1973 |